Pharmacokinetics and Clinical Effects of Escalating Doses of Clonidine in ICU Patients
NCT02466373
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Delirium
Critical Illness
Interventions
DRUG:
Clonidine (Catapresan®) 0,150 mg/ml, ampoule 1 ml
Sponsor
Deventer Ziekenhuis